Table 1 Demographics of participants
All participants (N = 50) | RTRs (N = 25) | GD Patients (N = 25) | p-value | |
|---|---|---|---|---|
Median age (Min-Max) (SD), years | 62 (20–78) | 61 (37–74) | 65 (20–78) | 0.253 |
(13.5) | (11.38) | (15.3) | ||
Sex (N) | ||||
Female | 21 (42.0) | 9 (36.0) | 12 (48.0) | 0.567 |
Male | 29 (58.0) | 16 (64.0) | 13 (52.0) | |
Race (N, %) | ||||
Caucasian | 47 (94.0) | 50 (100.0) | 22 (88.0) | 0.235 |
Asian | 3 (6.0) | 0 | 3 (12.0) | |
Personal history of skin cancer (N, %) | ||||
Yes | 27 (54.0) | 18 (72.0) | 9 (36.0) | 0.022 |
No | 23 (46.0) | 7 (28.0) | 16 (64.0) | |
Formal education (Min-Max) (SD), years | 11.9 (4.0–19.0) (3.3) | 11.9 (4.0–19.0) (3.4) | 11.9 (6.0–18.5) (3.3) | 0.983 |
Median time since the first dose of immunosuppressants (IQR), months | 62.0 (36.8–108.5) | 63.0 (35.5–111.5) | 61.0 (38.5–97.5) | 0.512 |